8-K
Current Report
Amphastar Pharmaceuticals, Inc. Filed Acc 0001297184-21-000029
Material agreement · Acquisition or sale completed · Executive or director change · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading amph-20210506x8k.htm…